Importantly, BCAM was recently identified as target of miR-199a-5p in skin keratinocytes, where it acts as a tumor suppressor by inhibiting invasiveness [50], and in placenta, where it inhibits trophoblast proliferation, migration and invasion [51]. The gene discussed is BCAM; the disease is neoplasm.